NOT-HL-18-584: Notice of Expiration of RFA-HL-17-012 "Small Market Awards: SBIR Phase IIB Competing Renewals for Heart, Lung, Blood, and Sleep Technologies with Small Commercial Markets (R44)"

Notice of Expiration of RFA-HL-17-012 "Small Market Awards: SBIR Phase IIB Competing Renewals for Heart, Lung, Blood, and Sleep Technologies with Small Commercial Markets (R44)"

Notice Number: NOT-HL-18-584

Key Dates
Release Date: January 24, 2018

Related Announcements
RFA-HL-17-012

Issued by
National Heart, Lung, and Blood Institute (NHLBI)

Purpose

The purpose of this Notice is to announce the expiration of RFA-HL-17-012 "Small Market Awards: SBIR Phase IIB Competing Renewals for Heart, Lung, Blood, and Sleep Technologies with Small Commercial Markets (R44)". This will negate the FOA's final receipt date. The IC plans to reissue the FOA in time for a new June application due date. The reissued FOA will contain necessary language for the FORMS-E application package and will accept clinical trials.

Currently Reads:
Expiration Date: June 21, 2018

Modified to read:
Expiration Date: January 24, 2018

All other aspects of the FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Gary Robinson, PhD
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-827-7978
[email protected]